艾灸结合健康信念模式干预痰浊阻遏型血脂异常临床观察

Intervention Study of Moxibustion Combined with Health Belief Mode on Hyperlipidemia of Turbid Phlegm Retention Type

目的:观察艾灸结合健康信念模式干预痰浊阻遏型血脂异常的临床疗效。方法:采用随机数字表法将60例血脂异常患者分为对照组与观察组各30例。对照组接受常规健康教育,观察组接受艾灸治疗及健康信念模式指导下的健康教育,艾灸穴位选择丰隆、中脘、足三里,每日一次,每次30 min,疗程为6周。比较两组治疗前后血脂指标、中医证候积分、血脂健康知识评分及临床疗效。结果:观察组治疗后的的血脂指标、中医证候积分、血脂健康知识评分较治疗前均有改善(P<0.05或P<0.01),对照组治疗后中医证候积分降低(P<0.05),其余指标无明显改变(P>0.05),两组比较,以上指标差异均有统计学意义(P<0.05或P<0.01);观察组治疗总有效率63.33%,对照组13.33%,两组疗效比较差异有统计学意义(P<0.01)。结论:艾灸结合以健康信念模式为指导的健康教育可对痰浊阻遏型血脂异常患者实现有效降脂,并改善临床症状。

Objective:To observe the clinical effect of moxibustion combined with health belief mode(HBM)on dyslipidemia of turbid phlegm retention type.Methods:Sixty patients with dyslipidemia were divided into control group and observation group by random number table method,30 patients in each group.The control group received routine health education,while the observation group received moxibustion treatment and health education under the guidance of HBM.Moxibustion was conducted on Fenglong(ST 40),Zhongwan(CV 12)and Zusanli(ST 36),once a day,30 minutes each time,for 6 weeks.Blood lipid index,traditional Chinese medicine(TCM)syndrome score and blood lipid health knowledge score were compared between the two groups before and after treatment.The clinical efficacy were compared between the two groups after treatment.Results:The blood lipid index,TCM syndrome score and blood lipid health knowledge score of the observation group after treatment were improved compared with those before treatment(P<0.05 or P<0.01).The syndrome score of the control group before treatment decreased compared with after treatment(P<0.05),without changes on other indexes(P>0.05).After treatment,there were statistically signifisant differences in the indexes between both groups(P<0.05 or P<0.01).The total efficacy in the observation group was 63.33%,while in the control group was 13.33%,with statistically signifisant difference between both groups.Conclusion:Moxibustion combined with health education guided by HBM can improve the blood lipid index of patients with dyslipidemia of turbid phlegm retention and improve clinical symptoms.